{"id":"W3019492746","doi":"10.1177/0333102420920642","title":"Assessment of immunogenicity from galcanezumab phase 3 trials in patients with episodic or chronic migraine","year":2020,"lang":"en","type":"article","venue":"Cephalalgia","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Medicine; Immunogenicity; Calcitonin gene-related peptide; Placebo; Antibody; Chronic Migraine; Pharmacokinetics; Internal medicine; Adverse effect; Migraine; Antibody titer; Immunology; Pharmacology; Titer; Pathology; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004189631,0.0002339187,0.001326186,0.00008873882,0.00004061041,0.000007413852,0.0001134551,0.00007967863,0.001361988],"category_scores_gemma":[0.0006125562,0.0001516626,0.000198789,0.0003585413,0.00009275072,0.00005876323,0.00006264137,0.0002469795,0.00001297478],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001596305,"about_ca_system_score_gemma":0.0004368242,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003933616,"about_ca_topic_score_gemma":0.0001628628,"domain_scores_codex":[0.9979705,0.0001740492,0.0008370232,0.0003438116,0.0003909065,0.0002837185],"domain_scores_gemma":[0.9988251,0.0002823624,0.0003047631,0.0002971108,0.0001359389,0.0001546834],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008702707,0.003410288,0.9253379,0.001000504,0.001761321,0.0001516476,0.003622038,0.00001047627,0.02431689,0.00008782472,0.02569281,0.005905637],"study_design_scores_gemma":[0.03988764,0.006045956,0.9460052,0.0003535117,0.0004885998,0.000001523436,0.0002601024,0.0002314242,0.002678923,0.00001743791,0.003809015,0.0002206666],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955327,0.001212208,0.0001436346,0.00136834,0.00002692423,0.0009535694,0.0001605019,0.00003402026,0.0005680813],"genre_scores_gemma":[0.9979687,0.0001469806,0.0007479216,0.0004016779,0.0001719145,0.00003741646,0.0002434872,0.0000262766,0.0002556176],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03118493,"threshold_uncertainty_score":0.9995509,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05335005656755624,"score_gpt":0.359268087055071,"score_spread":0.3059180304875147,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}